LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Journal Article > Research

Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation: the Human Papillomavirus–Automated Visual Evaluation Consortium

Befano B, Kalpathy-Cramer J, Egemen D, Inturrisi F, Jeronimo J, Rodríguez AC, Campos N, Cremer M, Ribeiro A, Ajenifuja KO, Goldstein A, Haider A, Yeates K, Madeleine M, Norris T, Figueroa J, Alfaro K, Raiol T, Adepiti C, Norman J, Chilinda GK, Mchome B, Donastorg Y, Dlamini X, Conzuelo G, Banjo AA, Chone P, Mremi A, Benitez A, Rosberger Z, Vantha T, Prieto-Egido I, Boyd-Morin J, Clark C, Kinder S, Wentzensen N, Desai K, Perkins R, de Sanjosé S, Schiffman M
Abstract

The HPV-Automated Visual Evaluation (PAVE) Consortium is validating a cervical screening strategy enabling accurate cervical screening in resource-limited settings. A rapid, low-cost HPV assay permits sensitive HPV testing of self-collected vaginal specimens; HPV-negative women are reassured. Triage of positives combines HPV genotyping (four groups in order of cancer risk) and visual inspection assisted by automated cervical visual evaluation (AVE) that classifies cervical appearance as severe, indeterminate, or normal. Together, the combination predicts which women have precancer, permitting targeted management to those most needing treatment.


We analyzed CIN3+ yield for each PAVE risk level (HPV genotype crossed by AVE classification) from nine clinical sites (Brazil, Cambodia, Dominican Republic, El Salvador, Eswatini, Honduras, Malawi, Nigeria, and Tanzania). Data from 1832 HPV-positive participants confirmed that HPV genotype and AVE classification each strongly and independently predict risk of histologic CIN3+. The combination of these low-cost tests provided excellent risk stratification, warranting pre-implementation demonstration projects.

Countries
American SamoaBrazilCambodiaDominican RepublicEl SalvadorEswatiniHondurasMalawiNigerNigeriaTanzania
Subject Area
cancercervical cancerdisease surveillancehuman papilloma virus (HPV)sexually transmitted infections
DOI
10.1093/jnci/djaf054
Published Date
18-Mar-2025
PubMed ID
40109247
Languages
English
Journal
Journal of the National Cancer Institute
Dimensions Badge